Research-grade peptides, Canadian standards.

The strongest weight-loss numbers in the catalog — 24.2% of body weight over 48 weeks, against 2.1% on placebo.

The repair stack — two peptides in one vial, one working on blood supply into damaged tissue and the other on the actin machinery of wound and soft-tissue healing.

The growth-hormone releaser — a stabilised fragment of GHRH that signals the pituitary to make its own growth hormone rather than replacing it.

The mitochondrial peptide — studied for endurance, insulin sensitivity and the physical decline that comes with age.

The visceral-fat peptide — approved for deep abdominal fat in HIV-associated lipodystrophy, which it cut 15.2% against a 5.0% increase on placebo.

The copper skin peptide — applied topically, it closed a median 98.5% of diabetic ulcer area against 60.8% under vehicle.

The coenzyme every cell already runs on, not a peptide — studied for everyday energy, insulin sensitivity and the NAD+ that falls away with age.

FDA-approved for low sexual desire in premenopausal women — only the second medicine ever approved for it, and it works on desire in the brain rather than on blood flow.

The copper peptide for hair — studied for follicle growth and the cells that drive it, built on the same copper-binding chemistry as GHK-Cu.

The repair peptide — studied for tendon and ligament healing, gut lining, and getting blood flow into damaged tissue.

Two routes into the same growth-hormone signal — a GHRH-receptor analogue paired with ipamorelin, the selective growth-hormone secretagogue.

A sleep-research peptide — 59% more total sleep than placebo in a single-dose trial.

The telomere peptide — studied for cellular aging, telomerase activity, and how many more times a cell can keep dividing.

The repair stack — BPC-157, TB-500 and GHK-Cu in one vial, for soft-tissue recovery, wound closure and skin collagen.

The selective growth hormone peptide — a GH pulse without the ACTH and cortisol rise the older secretagogues bring.

A reproductive-axis signalling peptide — infusion raised LH to 10.8 U/L against 4.2 U/L on saline.

The repair stack — four peptides in one vial: BPC-157 and TB-500 for tissue, KPV for inflammation, GHK-Cu for skin and collagen.

The anti-inflammatory tripeptide — studied for gut inflammation, skin irritation and surface wounds, and it calms inflammation without the skin-darkening its parent hormone carries.

An anxiety-research peptide compared head-to-head against the benzodiazepine medazepam, matching it across the anxiety scales used in that trial.

The GLP-1 benchmark every newer weight-loss compound is measured against — 14.9% of body weight over 68 weeks, against 2.4% on placebo.

A neurotrophin-research peptide — raises BDNF and has been studied in post-stroke rodent models.

A growth-hormone-releasing peptide — a two-week trial in men averaging 68 raised 24-hour growth hormone and IGF-I to levels seen in untreated men in their twenties.

The mitochondrial peptide — it targets the inner membrane where energy is made, and it carries an FDA accelerated approval for Barth syndrome, a rare inherited cardiolipin disorder.

The tissue-repair peptide built on thymosin beta 4 — studied for wound and skin healing, fracture and soft-tissue recovery, and inflammation at an injury site.

The dual-receptor incretin that beat semaglutide outright — 20.2% of body weight lost, against 13.7%.

A small-molecule enzyme inhibitor studied for its effects on body fat and muscle strength.

An 11-amino-acid peptide modelled on one face of erythropoietin's helix B, built to reach its tissue-repair receptor and not its red-blood-cell one.

The body's most abundant cellular antioxidant, studied for skin tone, redox balance and immune-cell activity.

A melanocortin-1 receptor agonist that drives eumelanin production in the skin without ultraviolet exposure, taking the pigment route to photoprotection rather than filtering light at the surface.

A synthetic analogue of the body's own alpha-MSH signal, studied for skin pigmentation and for erectile response.

The tripeptide Glu-Asp-Arg from the Russian short-peptide programme, studied as a neuroprotective and geroprotective candidate.

A topical cosmetic peptide used in formulations aimed at the look of expression lines.

A single-vial formulation of nine amino acids and amino-acid derivatives, led by L-carnitine, L-citrulline and L-arginine.

An injectable blend of L-carnitine with the methionine-inositol-choline lipotropics, vitamins B6 and B12, and NADH.

An injectable blend of L-carnitine, a methionine/inositol/choline lipotropic mix, ATP and vitamin B12 that also contains albuterol, a prescription beta-2 agonist bronchodilator.